{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:06:41Z","timestamp":1790741201795,"version":"4.1.0"},"reference-count":125,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Quinolones are broad-spectrum synthetic antibacterial drugs first obtained during the synthesis of chloroquine. Nalidixic acid, the prototype of quinolones, first became available for clinical consumption in 1962 and was used mainly for urinary tract infections caused by Escherichia coli and other pathogenic Gram-negative bacteria. Recently, significant work has been carried out to synthesize novel quinolone analogues with enhanced activity and potential usage for the treatment of different bacterial diseases. These novel analogues are made by substitution at different sites\u2014the variation at the C-6 and C-8 positions gives more effective drugs. Substitution of a fluorine atom at the C-6 position produces fluroquinolones, which account for a large proportion of the quinolones in clinical use. Among others, substitution of piperazine or methylpiperazine, pyrrolidinyl and piperidinyl rings also yields effective analogues. A total of twenty six analogues are reported in this review. The targets of quinolones are two bacterial enzymes of the class II topoisomerase family, namely gyrase and topoisomerase IV. Quinolones increase the concentration of drug-enzyme-DNA cleavage complexes and convert them into cellular toxins; as a result they are bactericidal. High bioavailability, relative low toxicity and favorable pharmacokinetics have resulted in the clinical success of fluoroquinolones and quinolones. Due to these superior properties, quinolones have been extensively utilized and this increased usage has resulted in some quinolone-resistant bacterial strains. Bacteria become resistant to quinolones by three mechanisms: (1) mutation in the target site (gyrase and\/or topoisomerase IV) of quinolones; (2) plasmid-mediated resistance; and (3) chromosome-mediated quinolone resistance. In plasmid-mediated resistance, the efflux of quinolones is increased along with a decrease in the interaction of the drug with gyrase (topoisomerase IV). In the case of chromosome-mediated quinolone resistance, there is a decrease in the influx of the drug into the cell.<\/jats:p>","DOI":"10.3390\/molecules21040268","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T16:00:28Z","timestamp":1459267228000},"page":"268","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":195,"title":["The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity"],"prefix":"10.3390","volume":"21","author":[{"given":"Abdul","family":"Naeem","sequence":"first","affiliation":[{"name":"National Center of Excellence in Physical Chemistry, University of Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-1425","authenticated-orcid":false,"given":"Syed","family":"Badshah","sequence":"additional","affiliation":[{"name":"National Center of Excellence in Physical Chemistry, University of Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"},{"name":"Department of Chemistry, Islamia College University Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairman","family":"Muska","sequence":"additional","affiliation":[{"name":"National Center of Excellence in Physical Chemistry, University of Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Islamia College University Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-6976","authenticated-orcid":false,"given":"Khalid","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Islamia College University Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the united states during the 20th century","volume":"281","author":"Armstrong","year":"1999","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm500942v","article-title":"Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of plasmodium","volume":"57","author":"Cross","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/antibiotics2020288","article-title":"Multiple pathways of genome plasticity leading to development of antibiotic resistance","volume":"2","author":"Baharoglu","year":"2013","journal-title":"Antibiotics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkp255","article-title":"Has the era of untreatable infections arrived?","volume":"64","author":"Livermore","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/acs.orglett.5b00248","article-title":"Direct synthesis of 2-aryl-4-quinolones via transition-metal-free intramolecular oxidative C (sp3)-H\/C(sp3)-H coupling","volume":"17","author":"Hu","year":"2015","journal-title":"Org. Lett."},{"key":"ref_7","first-page":"455","article-title":"Quinolones: A comprehensive review","volume":"65","author":"Oliphant","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1,8-naphthyridine derivatives. A new class of chemotherapeutic agents","volume":"5","author":"Lesher","year":"1962","journal-title":"J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/ol503292p","article-title":"Practical route to 2-quinolinones via a pd-catalyzed C-H bond activation\/C-C bond formation\/cyclization cascade reaction","volume":"17","author":"Wu","year":"2014","journal-title":"Org. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: Decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1086\/428051","article-title":"The quinolones: Past, present, and future","volume":"41","author":"Andriole","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: An expanded \u201cdiscovery story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial topoisomerase inhibitors: Quinolone and pyridone antibacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/molecules16032626","article-title":"Synthesis and in vitro antibacterial activity of 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl) fluoroquinolone derivatives","volume":"16","author":"Guo","year":"2011","journal-title":"Molecules"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_17","first-page":"587","article-title":"Fluoroquinolone antibacterials: A review on chemistry, microbiology and therapeutic prospects","volume":"66","author":"Sharma","year":"2009","journal-title":"Acta. Pol. Pharm."},{"key":"ref_18","first-page":"69","article-title":"Evolution of the quinolones","volume":"27","author":"Liu","year":"2006","journal-title":"World Notes Antibiot."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11005","DOI":"10.1021\/jf303222a","article-title":"Development of an improved method for trace analysis of quinolones in eggs of laying hens and wildlife species using molecularly imprinted polymers","volume":"60","author":"Blasco","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1021\/jm200015a","article-title":"Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships","volume":"54","author":"Cross","year":"2011","journal-title":"J. Med. Chem"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1021\/ol4006739","article-title":"Synthesis of 2 (1H)-quinolinones via Pd-catalyzed oxidative cyclocarbonylation of 2-vinylanilines","volume":"15","author":"Ferguson","year":"2013","journal-title":"Org. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1021\/acs.orglett.5b00641","article-title":"Rh (III) and Ru (II)-catalyzed site-selective C-H alkynylation of quinolones","volume":"17","author":"Kang","year":"2015","journal-title":"Org. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/acs.orglett.5b01654","article-title":"Chiral phosphoric acid catalyzed asymmetric synthesis of 2-substituted 2, 3-dihydro-4-quinolones by a protecting-group-free approach","volume":"17","author":"Saito","year":"2015","journal-title":"Org. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/jo302173a","article-title":"Per-6-amino-\u03b2-cyclodextrin as a chiral base catalyst promoting one-pot asymmetric synthesis of 2-aryl-2,3-dihydro-4-quinolones","volume":"78","author":"Kanagaraj","year":"2013","journal-title":"J. Org. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/jo502400h","article-title":"Synthesis of 4-quinolones via a carbonylative Sonogashira cross-coupling using molybdenum hexacarbonyl as a CO source","volume":"80","author":"Nordeman","year":"2015","journal-title":"J. Org. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1021\/jo5023958","article-title":"Metal-free arylation of ethyl acetoacetate with hypervalent diaryliodonium salts: An immediate access to diverse 3-aryl-4 (1H)-quinolones","volume":"80","author":"Monastyrskyi","year":"2015","journal-title":"J. Org. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/jo5027673","article-title":"Synthesis of quinolinones with palladium-catalyzed oxidative annulation between acrylamides and arynes","volume":"80","author":"Wang","year":"2015","journal-title":"J. Org. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/ol501548e","article-title":"Ruthenium-catalyzed cyclization of anilides with substituted propiolates or acrylates: An efficient route to 2-quinolinones","volume":"16","author":"Manikandan","year":"2014","journal-title":"Org. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/jm201184h","article-title":"Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH: Quinone oxidoreductase (PfNDH2)","volume":"55","author":"Leung","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s00044-011-9728-8","article-title":"Pyridoquinolones containing azetidinones: Synthesis and their biological evaluation","volume":"21","author":"Patel","year":"2011","journal-title":"Med. Chem. Res."},{"key":"ref_31","first-page":"39","article-title":"Novel pyridoquinolones of sulfonamides, thioureas and amines and their antimicrobial activity","volume":"15","author":"Patel","year":"2005","journal-title":"Indian J. Heterocycl. Chem."},{"key":"ref_32","first-page":"8","article-title":"Synthesis and antimicrobial activity of novel 6-hydroxy-4-oxo-pyrido[2,3-H]quinoline-3[(substituted aryl ureido\/piperazinyl)carbonyl]","volume":"44","author":"Patel","year":"2010","journal-title":"Indian J. Pharm. Educational Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00044-009-9228-2","article-title":"Synthesis and antimicrobial study of fluoroquinolone based 4-thiozolidinones","volume":"19","author":"Patel","year":"2010","journal-title":"Med. Chem. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00044-010-9345-y","article-title":"Synthesis and antimicrobial activities of 2-azetidinyl-4-quinazolinone derivatives of diclofenac analogue","volume":"20","author":"Patel","year":"2011","journal-title":"Med. Chem. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jscs.2010.07.004","article-title":"Synthesis and antimicrobial activity of carbonyl pyridoquinolones containing urea and piperazine residue","volume":"15","author":"Patel","year":"2010","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00044-010-9443-x","article-title":"Synthesis and in vitro microbial activities of amides of pyridoquinolone","volume":"20","author":"Patel","year":"2011","journal-title":"Med. Chem. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molstruc.2015.04.044","article-title":"Phosphine derivatives of sparfloxacin\u2014Synthesis, structures and in vitro activity","volume":"1096","author":"Komarnicka","year":"2015","journal-title":"J. Mol. Struct."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Parkinson, E.I., Bair, J.S., Nakamura, B.A., Lee, H.Y., Kuttab, H.I., Southgate, E.H., Lezmi, S., Lau, G.W., and Hergenrother, P.J. (2015). Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteria. Nat. Commun., 6.","DOI":"10.1038\/ncomms7947"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20984","DOI":"10.1074\/jbc.M115.663534","article-title":"Inhibition of Neisseria gonorrhoeae type II topoisomerases by the novel spiropyrimidinetrione azd0914","volume":"290","author":"Kern","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.35652\/IGJPS.2012.04","article-title":"Fluoroquinolones: Chemistry & action\u2014A review","volume":"2","author":"Soni","year":"2012","journal-title":"Indo Global J. Pharm. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mohammadhosseini, N., Alipanahi, Z., Alipour, E., Emami, S., Faramarzi, M., Samadi, N., Khoshnevis, N., Shafiee, A., and Foroumadi, A. (2012). Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety. DARU J. Pharm. Sci., 20.","DOI":"10.1186\/2008-2231-20-16"},{"key":"ref_43","first-page":"823","article-title":"Binding of norfloxacin, enoxacin and enrofloxacin to calf thymus DNA","volume":"57","author":"Vijan","year":"2012","journal-title":"Rev. Roum. Chim."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152607781001763","article-title":"Mycobacterium tuberculosis DNA gyrase as a target for drug discovery","volume":"7","author":"Mdluli","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hawtin, R.E., Stockett, D.E., Byl, J.A., McDowell, R.S., Nguyen, T., Arkin, M.R., Conroy, A., Yang, W., Osheroff, N., and Fox, J.A. (2010). Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010186"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics3030572","article-title":"Development and validation of a microbiological agar assay for determination of orbifloxacin in pharmaceutical preparations","volume":"3","author":"Cazedey","year":"2011","journal-title":"Pharmaceutics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/antibiotics3020193","article-title":"Beta-lactam antibiotics renaissance","volume":"3","author":"Qin","year":"2014","journal-title":"Antibiotics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/jf8030524","article-title":"Developing and optimizing an immunoaffinity cleanup technique for determination of quinolones from chicken muscle","volume":"57","author":"Zhao","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0025-7125(05)70297-2","article-title":"Clinical use of the fluoroquinolones","volume":"84","author":"Owens","year":"2000","journal-title":"Med. Clin. N. Am."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.bmcl.2016.01.012","article-title":"Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa","volume":"26","author":"Long","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1542\/peds.2011-1496","article-title":"The use of systemic and topical fluoroquinolones","volume":"128","author":"Bradley","year":"2011","journal-title":"Pediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1128\/AAC.00695-11","article-title":"Current prospects for the fluoroquinolones as first-line tuberculosis therapy","volume":"55","author":"Takiff","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijantimicag.2007.10.014","article-title":"Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates","volume":"31","author":"Sun","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Avalos, E., Catanzaro, D., Catanzaro, A., Ganiats, T., Brodine, S., Alcaraz, J., and Rodwell, T. (2015). Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: A systematic review. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120470"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1099\/jmm.0.046821-0","article-title":"Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin","volume":"62","author":"Nosova","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1574-6968.12401","article-title":"Mechanisms of fluoroquinolone monoresistance in mycobacterium tuberculosis","volume":"353","author":"Lu","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in china","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100362","article-title":"Advances in the treatment of tuberculosis","volume":"82","author":"Zhang","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.diagmicrobio.2012.03.025","article-title":"Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China","volume":"73","author":"Zhu","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JCM.01916-06","article-title":"Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from china as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing","volume":"44","author":"Shi","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jac\/dkm038","article-title":"Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from rwanda: Results of a national survey","volume":"59","author":"Umubyeyi","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1021\/acs.jmedchem.5b00079","article-title":"Novel pyridyl substituted 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability","volume":"58","author":"Hu","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1021\/acs.jmedchem.5b00159","article-title":"N-substituted quinolinonyl diketo acid derivatives as HIV integrase strand transfer inhibitors and their activity against RNase H function of reverse transcriptase","volume":"58","author":"Pescatori","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1021\/jm0511583","article-title":"Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, biological activities, and mechanism of action","volume":"49","author":"Roux","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2174\/092986711796504619","article-title":"Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain","volume":"18","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1021\/jm5001503","article-title":"Basic quinolinonyl diketo acid derivatives as inhibitors of hiv integrase and their activity against RNase H function of reverse transcriptase","volume":"57","author":"Costi","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1021\/jm8001422","article-title":"Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, and biological activities","volume":"51","author":"Roux","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3892\/ijo.2014.2611","article-title":"Ciprofloxacin containing Mannich base and its copper complex induce antitumor activity via different mechanism of action","volume":"45","author":"Fu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1939-1676.2006.tb00742.x","article-title":"Comparison of pharmacodynamics and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats","volume":"20","author":"Boothe","year":"2006","journal-title":"J. Vet. Inter. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-3164.2007.00584.x","article-title":"Pradofloxacin in the treatment of canine deep pyoderma: A multicentred, blinded, randomized parallel trial","volume":"18","author":"Mueller","year":"2007","journal-title":"Vet. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: Structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1021\/bi300645n","article-title":"Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase","volume":"51","author":"Dale","year":"2012","journal-title":"Biochemistry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/nar\/gkn937","article-title":"The DNA cleavage reaction of topoisomerase II: Wolf in sheep\u2019s clothing","volume":"37","author":"Deweese","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0401595101","article-title":"The c-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold","volume":"101","author":"Corbett","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","article-title":"DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities","volume":"1400","author":"Levine","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S003358350800468X","article-title":"DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology","volume":"41","author":"Schoeffler","year":"2008","journal-title":"Q. Rev. Biophys."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1381612013398013","article-title":"Type II topoisomerases as targets for quinolone antibacterials turning Dr. Jekyll into Mr. Hyde","volume":"7","author":"Anderson","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1042\/BST0331465","article-title":"Recent advances in understanding structure\u2014function relationships in the type II topoisomerase mechanism","volume":"33","author":"Schoeffler","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1093\/nar\/gkq665","article-title":"A domain insertion in Escherichia coli gyrB adopts a novel fold that plays a critical role in gyrase function","volume":"38","author":"Schoeffler","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature08974","article-title":"A novel and unified two-metal mechanism for DNA cleavage by type II and Ia topoisomerases","volume":"465","author":"Schmidt","year":"2010","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1093\/nar\/gkr018","article-title":"Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV","volume":"39","author":"Pitts","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bmb.20244","article-title":"DNA topology and topoisomerases","volume":"37","author":"Deweese","year":"2009","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Laponogov, I., Pan, X.-S., Veselkov, D.A., McAuley, K.E., Fisher, L.M., and Sanderson, M.R. (2010). Structural basis of gate-DNA breakage and resealing by type II topoisomerases. PLoS ONE, 5.","DOI":"10.1371\/annotation\/deacc2fd-665b-4736-b668-dc69a38bb4f9"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nsmb.1604","article-title":"Structural insight into the quinolone\u2013DNA cleavage complex of type IIa topoisomerases","volume":"16","author":"Laponogov","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/nar\/gkq799","article-title":"Solution structures of DNA-bound gyrase","volume":"39","author":"Baker","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/bi501073v","article-title":"Activity of quinolone cp-115,955 against bacterial and human type II topoisomerases is mediated by different interactions","volume":"54","author":"Aldred","year":"2015","journal-title":"Biochemistry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/jb.140.2.424-435.1979","article-title":"Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: Effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth","volume":"140","author":"Kreuzer","year":"1979","journal-title":"J. Bacteriol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hooper, D.C. (2003). Quinolone Antimicrobial Agents, ASM Press. [3rd ed.].","DOI":"10.1128\/9781555817817"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: Quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.44.8.2160-2165.2000","article-title":"Selective targeting of topoisomerase iv and DNA gyrase in Staphylococcus aureus: Different patterns of quinolone-induced inhibition of DNA synthesis","volume":"44","author":"Fournier","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1128\/AAC.47.7.2362-2365.2003","article-title":"In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin","volume":"47","author":"Price","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/AAC.00665-08","article-title":"Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates","volume":"53","author":"Boyd","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/jmbi.2001.4838","article-title":"Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions","volume":"311","author":"Sissi","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/nar\/gkp024","article-title":"Effects of magnesium and related divalent metal ions in topoisomerase structure and function","volume":"37","author":"Sissi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/AAC.45.7.1994-2000.2001","article-title":"Interaction between DNA gyrase and quinolones: Effects of alanine mutations at gyrA subunit residues Ser83 and Asp87","volume":"45","author":"Barnard","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Chan, P.F., Srikannathasan, V., Huang, J., Cui, H., Fosberry, A.P., Gu, M., Hann, M.M., Hibbs, M., Homes, P., and Ingraham, K. (2015). Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin. Nat. Commun., 6.","DOI":"10.1038\/ncomms10048"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIa topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1107\/S2053230X15015290","article-title":"Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide","volume":"71","author":"Srikannathasan","year":"2015","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIa topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1021\/bi500682e","article-title":"Role of the water metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1093\/nar\/gkt124","article-title":"Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: Mechanistic basis of quinolone resistance","volume":"41","author":"Aldred","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/bi2013905","article-title":"Drug interactions with Bacillus anthracis topoisomerase IV: Biochemical basis for quinolone action and resistance","volume":"51","author":"Aldred","year":"2012","journal-title":"Biochemistry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1021\/cb400592n","article-title":"Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions","volume":"8","author":"Aldred","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1568011054222364","article-title":"Etoposide, topoisomerase ii and cancer","volume":"5","author":"Baldwin","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"20359","DOI":"10.1074\/jbc.270.35.20359","article-title":"A mutation in yeast top2 homologous to a quinolone-resistant mutation in bacteria. Mutation of the amino acid homologous to Ser83 of Escherichia coli GyrA alters sensitivity to eukaryotic topoisomerase inhibitors","volume":"270","author":"Hsiung","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1073\/pnas.1115704109","article-title":"DNA cleavage and opening reactions of human topoisomerase ii\u03b1 are regulated via Mg2+-mediated dynamic bending of gate-DNA","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2388","article-title":"Structure of a topoisomerase ii-DNA-nucleotide complex reveals a new control mechanism for ATPase activity","volume":"19","author":"Schmidt","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Micobiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/AAC.00113-09","article-title":"Probing the differential interactions of quinazolinedione pd 0305970 and quinolones with gyrase and topoisomerase IV","volume":"53","author":"Pan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.46.2.413-419.2002","article-title":"Cleavable-complex formation by wild-type and quinolone-resistant streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones","volume":"46","author":"Yague","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/AAC.00362-07","article-title":"Determination of the primary target of a quinolone drug and the effect of quinolone resistance-conferring mutations by measuring quinolone sensitivity based on its mode of action","volume":"51","author":"Pfeiffer","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/156802609789630947","article-title":"Quinolones: Action and resistance updated","volume":"9","author":"Drlica","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.47.7.2242-2248.2003","article-title":"Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from shanghai, china","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10156-010-0120-2","article-title":"Plasmid-mediated quinolone resistance: An update","volume":"17","author":"Cano","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/AAC.42.12.3293","article-title":"Alteration in the gyra subunit of DNA gyrase and the parc subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis","volume":"42","author":"Li","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(06)70599-0","article-title":"The worldwide emergence of plasmid-mediated quinolone resistance","volume":"6","author":"Robicsek","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: A multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Pascual","year":"1998","journal-title":"Lancet"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of plasmid-mediated quinolone resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1093\/nar\/gkq1296","article-title":"Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: Conserved surface loops direct the activity of a qnr protein from a gram-negative bacterium","volume":"39","author":"Xiong","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1128\/AAC.01489-13","article-title":"Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC (6\u2032)-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro","volume":"57","author":"Guillard","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/07853890701195262","article-title":"Efflux pumps as antimicrobial resistance mechanisms","volume":"39","author":"Poole","year":"2007","journal-title":"Ann. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/AAC.40.5.1266","article-title":"Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones","volume":"40","author":"Goldman","year":"1996","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/268\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:21:24Z","timestamp":1760210484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":125,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["molecules21040268"],"URL":"https:\/\/doi.org\/10.3390\/molecules21040268","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}